Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Weight Reduction

17-alpha-hydroxyprogesterone has been researched along with Weight Reduction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farmakiotis, D; Katsikis, I; Kourtis, A; Krassas, G; Panidis, D; Rousso, D1
Jakubowicz, DJ; Nestler, JE1
Bonjer, J; Bootsma, AH; Bruining, H; de Jong , FF; Koper, JW; Lamberts, SW1
Chang, RJ1

Reviews

1 review(s) available for 17-alpha-hydroxyprogesterone and Weight Reduction

ArticleYear
[Polycystic ovaries in 2001: physiology and treatment].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 2002, Volume: 31, Issue:2 Pt 2

    Topics: 17-alpha-Hydroxyprogesterone; Androgen Antagonists; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Exercise; Female; Humans; Hypothalamus; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone; Ultrasonography; Weight Loss

2002

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and Weight Reduction

ArticleYear
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Fertility and sterility, 2008, Volume: 89, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Caloric Restriction; Case-Control Studies; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Lactones; Luteinizing Hormone; Obesity; Orlistat; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Weight Loss

2008

Other Studies

2 other study(ies) available for 17-alpha-hydroxyprogesterone and Weight Reduction

ArticleYear
17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Blood Glucose; Female; Gonadal Steroid Hormones; Humans; Insulin; Leuprolide; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Weight Loss

1997
Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocorticotropic Hormone; Body Composition; Dexamethasone; Estradiol; Female; Fertility; Fludrocortisone; Humans; Hydrocortisone; Laparoscopy; Menstrual Cycle; Progesterone; Time Factors; Treatment Outcome; Weight Loss

2001